Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.21 B
According to Cytokinetics 's latest financial reports the company's total liabilities are $1.21 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cytokinetics - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.21 B | 7.84% |
| 2022-12-31 | $1.12 B | 87.91% |
| 2021-12-31 | $0.59 B | 42.11% |
| 2020-12-31 | $0.42 B | 39.79% |
| 2019-12-31 | $0.30 B | 62.35% |
| 2018-12-31 | $0.18 B | 0.15% |
| 2017-12-31 | $0.18 B | 144.08% |
| 2016-12-31 | $75.78 M | 62.46% |
| 2015-12-31 | $46.64 M | 14.04% |
| 2014-12-31 | $40.9 M | 42.29% |
| 2013-12-31 | $28.74 M | 285.03% |
| 2012-12-31 | $7.46 M | 62.48% |
| 2011-12-31 | $4.59 M | -38.54% |
| 2010-12-31 | $7.47 M | -64.69% |
| 2009-12-31 | $21.17 M | -43.83% |
| 2008-12-31 | $37.68 M | -32.04% |
| 2007-12-31 | $55.45 M | -12.26% |
| 2006-12-31 | $63.2 M | 253.09% |
| 2005-12-31 | $17.9 M | -12.87% |
| 2004-12-31 | $20.54 M | -86.74% |
| 2003-12-31 | $0.15 B | 32.67% |
| 2002-12-31 | $0.11 B | 0.33% |
| 2001-12-31 | $0.11 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $90.92 B | 7,410.24% | 🇺🇸 USA |
 Trevena TRVN | $41.58 M | -96.57% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $86.3 M | -92.87% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.26 B | -77.99% | 🇺🇸 USA |
 Array Technologies ARRY | $1.09 B | -9.45% | 🇺🇸 USA |